Gastroenteritis Norovirus
6 clinical trials · Condition
◉ Watch Gastroenteritis Norovirus
| Record | Firm | Date |
|---|---|---|
| Phase I Norovirus Challenge Model (NCT04174560) | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-03-28 |
| Validation of a Boindicator as Monitoring Tool for Oyster Norovirus Outbreak (NCT06568380) | Central Hospital, Nancy, France | 2020-01-01 |
| NNITS-Nitazoxanide for Norovirus in Transplant Patients Study (NCT03395405) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-10-15 |
| Optimal Human Dose for GII.2 Norovirus (Snow Mountain) Challenge Studies (NCT02473224) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-10-28 |
| Phase I Study to Determine the Optimal Human Challenge Dose for a Norovirus GII.4 Challenge Stock (CIN-1) (NCT02337842) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-09-01 |
| New Challenge Pool of Norwalk Virus Inoculum (NCT00138476) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-08-01 |
Track Gastroenteritis Norovirus automatically
Every clearance here is in the API, with alerts when new ones post.